Upgrade to SI Premium - Free Trial

Syndax Pharmaceuticals (SNDX)

13.20 -0.05 (0.38%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/29/26)

Latest Headlines

Syndax’s Revuforj® (revumenib) Named to TIME’s Best Inventions of 2026 List October 15, 2026 4:01 PM - StreetInsider Stifel Reiterates Buy Rating on Syndax Pharmaceuticals (SNDX) October 13, 2026 9:44 AM - StreetInsider Syndax Pharmaceuticals (SNDX) call put ratio 1 call 1.3 puts into share price lower before the bell October 13, 2026 5:35 AM - StreetInsider Citi reiterates Buy rating on Syndax Pharmaceuticals after stock drop October 13, 2026 5:03 AM - StreetInsider Syndax Pharmaceuticals stock tumbles on failed IPF trial October 12, 2026 4:12 PM - StreetInsider Syndax's axatilimab fails IPF trial's primary endpoint October 12, 2026 4:01 PM - StreetInsider Syndax Announces Topline Results from MAXPIRe Phase 2 Trial of Axatilimab in Idiopathic Pulmonary Fibrosis October 12, 2026 4:01 PM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Syndax Pharmaceuticals (SNDX) October 12, 2026 6:53 AM - StreetInsider Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) October 2, 2026 4:01 PM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Syndax Pharmaceuticals (SNDX) October 1, 2026 6:56 AM - StreetInsider Jefferies Reiterates Buy Rating on Syndax Pharmaceuticals (SNDX) September 29, 2026 6:37 AM - StreetInsider Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) September 4, 2026 4:01 PM - StreetInsider Syndax Announces Participation in September Investor Conferences September 1, 2026 7:00 AM - StreetInsider Syndax Pharmaceuticals (SNDX) PT Lowered to $33 at UBS as Revuforj New Starts Decline August 21, 2026 7:39 AM - StreetInsider Syndax Pharmaceuticals (SNDX) PT Lowered to $40 at JPMorgan August 11, 2026 8:49 AM - StreetInsider Form SCHEDULE 13G Syndax Pharmaceuticals Filed by: STATE STREET CORP August 7, 2026 11:00 AM - SEC Filing Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) August 5, 2026 4:01 PM - StreetInsider Syndax Pharmaceuticals (SNDX) PT Lowered to $38 at H.C. Wainwright August 5, 2026 6:37 AM - StreetInsider Syndax Pharmaceuticals (SNDX) PT Lowered to $26 at BofA Securities August 5, 2026 5:08 AM - StreetInsider Syndax Pharmaceuticals (SNDX) Misses Q2 EPS by 7c August 4, 2026 4:10 PM - StreetInsider Form 10-Q Syndax Pharmaceuticals For: Jun 30 August 4, 2026 4:05 PM - SEC Filing Form 8-K Syndax Pharmaceuticals For: Aug 04 August 4, 2026 4:03 PM - SEC Filing Syndax Reports Second Quarter 2026 Financial Results and Provides Business Update August 4, 2026 4:01 PM - StreetInsider Syndax to Announce Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 4, 2026 July 28, 2026 7:00 AM - StreetInsider Full Article List